Latest News

Husain Evaluates Real-World Evidence for Immunotherapy in Stage III NSCLC
Husain Evaluates Real-World Evidence for Immunotherapy in Stage III NSCLC

February 24th 2024

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Hatim Husain, MD, explained the significance of the PACIFIC trial and its real-world counterpart PACIFIC-R looking at the use of durvalumab after chemotherapy and radiation in patients with unresectable stage III non–small cell lung cancer.

Roundtable Roundup: Stage IIB Lung Cancer
Roundtable Roundup: Stage IIB Lung Cancer

February 22nd 2024

Velcheti Addresses Promising Data with Repotrectinib in ROS1+ NSCLC
Velcheti Addresses Promising Data with Repotrectinib in ROS1+ NSCLC

February 20th 2024

Comprehensive Molecular Testing Needed for Frontline NSCLC Treatment
Comprehensive Molecular Testing Needed for Frontline NSCLC Treatment

February 19th 2024

FDA Accepts Dato-DXd Application for Non-Small Cell Lung Cancer
FDA Accepts Dato-DXd Application for Non-Small Cell Lung Cancer

February 19th 2024

More News